A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age

NCT07742644 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1860

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles
Mumps
Rubella
Varicella (Chickenpox)
Measles-Mumps-Rubella+Chickenpox Vaccine

Interventions

BIOLOGICAL: MMRVNS vaccine
BIOLOGICAL: MMRV vaccine
BIOLOGICAL: DTaP-IPV vaccine

Sponsor

GlaxoSmithKline